 |
Also known as: Oncaspar
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Pegaspargase.
No reviews have yet been submitted. Be the first to review this drug.
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive...
Results from a St. Jude Children's Research Hospital and the Children's Oncology Group study pinpoint genetic basis for increased leukemia...
75% of patients who received the selected dose and schedule achieved a complete remission, with no detectable leukemic cells remaining Median survival not...
The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL),...
The Food and Drug Administration has approved a new chemotherapy designed to treat childhood leukemia patients who are allergic to standard treatments. The...
Looking for answers? Ask a question or go join the pegaspargase support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
